SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-092400
Filing Date
2022-08-18
Accepted
2022-08-18 09:07:35
Documents
9
Period of Report
2022-09-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2219817-7_def14a.htm DEF 14A 860235
2 GRAPHIC lg_invivotherape-4clr.jpg GRAPHIC 31918
3 GRAPHIC sg_richardtosellimd-bw.jpg GRAPHIC 10086
4 GRAPHIC tm2219817d1-pc_appena14c.jpg GRAPHIC 1388123
5 GRAPHIC tm2219817d1-pc_appena24c.jpg GRAPHIC 1048828
6 GRAPHIC tm2219817d1-pc_appenb14c.jpg GRAPHIC 1388123
7 GRAPHIC tm2219817d1-pc_appenb24c.jpg GRAPHIC 1048828
8 GRAPHIC tm2219817d7-px_01invivobw.jpg GRAPHIC 752416
9 GRAPHIC tm2219817d7-px_02invivobw.jpg GRAPHIC 768815
  Complete submission text file 0001104659-22-092400.txt   9719099
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 221176409
SIC: 3841 Surgical & Medical Instruments & Apparatus